MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
MSFT   202.43 (-2.24%)
FB   234.68 (-1.81%)
AMZN   2,995.37 (-3.50%)
NVDA   394.50 (-1.89%)
BABA   244.39 (-2.89%)
MU   48.30 (-2.35%)
GE   6.69 (-0.30%)
AMD   52.81 (-1.47%)
T   29.90 (+0.40%)
F   6.18 (+1.81%)
NFLX   505.50 (-3.81%)
BAC   23.86 (-1.41%)
Log in

OTCMKTS:AXIMAxim Biotechnologies Stock Price, Forecast & News

$0.25
-0.03 (-10.72 %)
(As of 07/14/2020 09:09 AM ET)
Add
Compare
Today's Range
$0.21
Now: $0.25
$0.28
50-Day Range
$0.27
MA: $0.37
$0.55
52-Week Range
$0.10
Now: $0.25
$0.95
Volume326,900 shs
Average Volume311,174 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Axim Biotechnologies, Inc., a biotechnology company, researches, develops, produces, and sells pharmaceutical, nutraceutical, and cosmetic products. It also engages in the extraction and purification of cannabinoids technologies based on its proprietary technologies. The company sells its products through Internet, direct-to-consumer health and wellness stores, collectives, cooperatives, and affiliate sales and master distributors. Axim Biotechnologies, Inc. was formerly known as Axim International Inc. and changed its name to Axim Biotechnologies, Inc. in July 2014. The company was founded in 2010 and is headquartered in New York, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.44 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:AXIM
CUSIPN/A
Phone212-751-0001

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4
Next Earnings DateN/A
OptionableNot Optionable

Receive AXIM News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter.

Axim Biotechnologies (OTCMKTS:AXIM) Frequently Asked Questions

How has Axim Biotechnologies' stock been impacted by COVID-19 (Coronavirus)?

Axim Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AXIM stock has increased by 40.3% and is now trading at $0.2499. View which stocks have been most impacted by Coronavirus.

Has Axim Biotechnologies been receiving favorable news coverage?

Media coverage about AXIM stock has trended somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Axim Biotechnologies earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Axim Biotechnologies.

Who are some of Axim Biotechnologies' key competitors?

What other stocks do shareholders of Axim Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axim Biotechnologies investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), Charlotte's Web (CWBHF), KushCo (KSHB), Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Tilray (TLRY), Aurora Cannabis (ACB) and CV Sciences (CVSI).

Who are Axim Biotechnologies' key executives?

Axim Biotechnologies' management team includes the following people:
  • Dr. George E. Anastassov, Founder & Chairman (Age 56)
  • Mr. John W. Huemoeller II, CEO & Director (Age 64)
  • Mr. Robert T. Malasek, CFO & Sec. (Age 51)
  • Mr. Lekhram Changoer, CTO & Director (Age 52)
  • Dr. Philip A. Van Damme D.M.D., M.D., DMD, MD, Ph.D., Chief Medical Officer & Director (Age 66)

What is Axim Biotechnologies' stock symbol?

Axim Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."

How do I buy shares of Axim Biotechnologies?

Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Axim Biotechnologies' stock price today?

One share of AXIM stock can currently be purchased for approximately $0.25.

What is Axim Biotechnologies' official website?

The official website for Axim Biotechnologies is aximbiotech.com.

How can I contact Axim Biotechnologies?

The company can be reached via phone at 212-751-0001.

This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.